Lv1
40 积分 2024-09-03 加入
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
1天前
已完结
[Expert consensus on the out-of-hospital management of myelosuppression associated with oncological treatment (2025 edition)]
26天前
已完结
Defining the Rates of Cytokine Release Syndrome Associated with Talquetamab Step-up Doses
2个月前
已关闭
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
2个月前
已关闭
Sepsis and septic shock
4个月前
已完结
[Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)]
4个月前
已完结
Guidelines for diagnosis and treatment of chronic gastritis inChina(2022,Shanghai)
5个月前
已完结
Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review
5个月前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
5个月前
已完结
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
7个月前
已完结
皖公网安备34019202002308
